Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

NCT00290355 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer, Non-Small Cell

Interventions

BIOLOGICAL: GSK 249553 vaccine
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline